Karen Kelly, MD, Discusses When to Start Immunotherapy

News
Article

Karen Kelly, MD, sat down to discuss her presentation on when to start immunotherapy in a real world, patient setting.

Karen Kelly, MD, of the University of California, Davis, talks about her work in examining when patients should start treatment with immunotherapy at the 17thAnnual Winter Lung Conference in Miami Beach, Florida.

Transcription:

I think that this is a really important question in the real world. Although the data is overwhelming and compelling that you should start an immunotherapy with your very first treatment in advanced disease, for the majority of patients who don’t have an oncogenic driver, we have 8 randomized trials showing that the combination with chemotherapy’s efficacious as well as 3 trials showing that monotherapy also is a reasonable first choice option.

And so that is a lot of data, but in the real world, our patients don’t always follow that clinical trial playbook. And sometimes we can’t actually start the IO in the actual cycle 1 which is how they were started in the clinical trials.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Hydration and a healthy, well-balanced diet may mitigate fatigue among patients undergoing treatment for cancer.
Bland foods, such as crackers and chicken noodle soup, as well as fluids with electrolytes, may help stave off treatment-related nausea.
According to Denise B. Reynolds, RD, patients eating well should not be experiencing nutritional deficiencies during cancer treatment.